$AYTU $DFFN $TNXP $AIM Probably a once-in-a lifetime opportunity: Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19. Relief therapeutics (rlftf, or buy it on the Swiss exchange rlf.sw) has fast tack designation and COMPASSIONATE USE. globenewswire.com/news-rele... Furthermore: Last 4 recent Management Transactions were all purchases: 03.07.2020 RELIEF THERAPEUTICS Holding SA Purchase Registered shares 145'655 CHF 5'080.90 03.07.2020 RELIEF THERAPEUTICS Holding SA Purchase Registered shares 125'000 CHF 4'800.00 30.06.2020 RELIEF THERAPEUTICS Holding SA Purchase Registered shares 2'500'000 CHF25'000.00 29.06.2020 RELIEF THERAPEUTICS Holding SA Purchase Registered shares 298'356 CHF 10'502.13 ser-ag.com/en/resources/not... New emergency COVID-19 drug in testing phase excites Florida doctors wsvn.com/news/local/new-eme... Also this very interesting case report: preprints.org/manuscript/20...
  • 3
3 Likes